Cambridge Major Laboratories, Inc. and AAIPharma Services Corp. have joined to form a world-class supplier of comprehensive pharmaceutical development and manufacturing services. With nearly 800 employees operating out of seven sites in the US and Europe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (solid dose and parenteral), packaging, and stability services.
Our reputation for providing solutions and expertise to solve our clients most difficult and challenging issues is unparalleled. We’ll do whatever it takes to get the job done safely, efficiently, and on specification.
We have established a new Center of Excellence for Crystallization and Solid State Chemistry in our Active Pharmaceutical Ingredient (API) development facilities in the Netherlands.
Our facilities house state-of-the-art analytical laboratories and controlled environmental chambers to support ICH stability studies.